“Prognostic Value of KRAS G12C in Advanced Non-Small Cell Lung Cancer With High PD-L1 Expression Treated With Upfront Immunotherapy: A Systematic Review and Meta-Analysis”. 2024. Swiss Medical Weekly 154 (7): 3695. https://doi.org/10.57187/s.3695.